Afatinib in advanced non-small-cell lung cancer

By Di Maio Massimo   Gridelli Cesare   Grossi Francesco   Novello Silvia   de Marinis Filippo  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 493-504

Future Medicine

Access to resources Recommend Favorite

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa   Ge Wei   Zhang Ling   Zhao Zhenyu   Jie Fangfang  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer

By Yanaihara Tomoko   Yokoba Masanori   Onoda Sayaka   Yamamoto Michiko   Ryuge Shinichiro   Hagiri Shintaro   Katagiri Masato   Wada Mayuko   Mitsufuji Hisashi   Kubota Masaru   Arai Susumu   Kobayashi Hirosuke   Yanase Nobuo   Abe Tadashi   Masuda Noriyuki  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 419-427

Springer Publishing Company

Access to resources Recommend Favorite

Conference Scene: Australia Lung Cancer Conference 2012: focus on systemic treatment of advanced non-small-cell lung cancer

By Vincent Mark  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 27-30

Future Medicine

Access to resources Recommend Favorite